Untreated MZL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL (NCT06985472) | Li Zhiming | 2024-11-13 |
Track Untreated MZL automatically
Every clearance here is in the API, with alerts when new ones post.